Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01892592 · ClinicalTrials.gov registry record · NA
Discovering Healthcare Innovations to Address Disparities in Stroke (DIADS)
A NA study, sponsored by Kaiser Permanente.
- Completed
- Registry status
- NA
- Development phase
- 1,761
- Enrollment target
NCT01892592: Completed NA study, sponsored by Kaiser Permanente.
NCT01892592 is a NA study that has completed, run by Kaiser Permanente. The registered enrollment target is 1,761 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (25% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01892592, a NA study, has completed, sponsored by Kaiser Permanente.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,761 participants
- Enrollment target
Study Summary
The goal of this pragmatic study is to improve hypertension (HTN) control rate in blacks and to reduce racial disparity in HTN control. To accomplish this, the investigators propose to perform a cluster randomized controlled trial at the primary care provider (PCP) level and including 191 PCPs within KPNC East Bay Service Area with more than 45,000 patients in the HTN registry of which approximately 15,000 are black. The investigators will randomize all PCP patient panels to a three-arm trial to receiving either 1) usual care; or 2) culturally tailored diet and lifestyle coaching; or 3) an intensified BP management protocol with pharmacotherapy. The "Shake, Rattle and Roll" trial is named for: 1) "shake" the salt habit; 2) "rattle" the intensity of current BP management; and 3) design the interventions with the goal of being able to adapt and "roll" them out to community clinics outside of a managed care system. Primary research question: whether a primary prevention intervention of either diet and lifestyle coaching or an intensive pharmacotherapy protocol is more effective than usual care in improving rates of HTN control in blacks and thereby reducing disparities between black and white. Primary aim: By implementing either intervention, the investigators will reduce the disparity in hypertension control rates between blacks and whites by 4% at 1 year post-study enrollment. Hypothesis: Among blacks with HTN, a diet/lifestyle coaching intervention or an intensified BP management protocol will result in an increase in HTN control rate compared to usual care. Primary outcome: the proportion of patients with sustained BP control at 1 year post-study enrollment.
Primary Outcome
Percentage of Blacks / African Americans with HTY with controlled blood pressure (BP) after 1 year.
Interventions
- BEHAVIORAL Diet and Lifestyle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,761 participants |
| Start Date | 2013-06 |
| Est. Completion | 2018-06 |
| Phase | NA |
What the finished NCT01892592 record still lists
NCT01892592 is an interventional study that assigns participants to a tested intervention. Its 1,761 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (25% higher).
The record links to 0 conditions, and to 1 intervention - of which Diet and Lifestyle is the first listed.
NCT01892592 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01892592 about?
NCT01892592 is a clinical study titled "Discovering Healthcare Innovations to Address Disparities in Stroke (DIADS)". The goal of this pragmatic study is to improve hypertension (HTN) control rate in blacks and to reduce racial disparity in HTN control. To accomplish this, the investigators propose to perform a cluster randomized controlled trial at the primary care provider (PCP) level and including 191 PCPs withi...
What is the current status of trial NCT01892592?
This trial is currently completed. It is a NA study. The enrollment target is 1,761 participants. The study started on 2013-06. Estimated completion is 2018-06.
What interventions are being tested in trial NCT01892592?
The interventions under investigation include: Diet and Lifestyle (BEHAVIORAL).
Who is sponsoring clinical trial NCT01892592?
This trial is sponsored by Kaiser Permanente, which has 294 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01892592's enrollment target sits among peer trials
1,761 61st of 2000 higher than 1,940 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06239688 · 1,764 participants · NA
Evaluating a National Person-Centered Training Program to Strengthen the Dementia Care Workforce
- NCT06872892 · 1,755 participants · Phase 3
The AIRTIVITY™ Study: A Study to Find Out Whether BI 1291583 Helps People With Bronchiectasis
- NCT07062172 · 1,753 participants · NA
Lung Cancer Screening of Family Members of Patients With Mutation-Driven Lung Cancer
- NCT05934487 · 1,750 participants · NA
PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia